1. Circulating predictive markers of immune checkpoint inhibitors in non-small cell lung cancer
   A. A. Musaelyan et al, 2021, Advances in Molecular Oncology CrossRef
2. PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome
   Sandra Lassalle et al, 2020, International Journal of Molecular Sciences CrossRef
3. TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model
   Nourridine Siewe et al, 2021, PLOS ONE CrossRef
4. Quantifying the contribution of transcription factor activity, mutations and microRNAs to CD274 expression in cancer patients
   Imke B. Bruns et al, 2022, Scientific Reports CrossRef
5. CT Image-Based Radiomic Analysis for Detecting PD-L1 Expression Status in Bladder Cancer Patients
   Ying Cao et al, 2024, Academic Radiology CrossRef
6. Five years after PACIFIC: update on multimodal treatment efficacy based on real-world reports
   Farkhad Manapov et al, 2023, Expert Opinion on Investigational Drugs CrossRef
7. Luptând cu boala la 83 de ani: supravieţuire în cazul infecţiei cu SARS-CoV-2 la o pacientă cu adenocarcinom pulmonar PD-L1 negativ, care a răspuns la tratament anti-PD-1 – prezentare de caz
   Maria Nedelcu et al, 2022, Oncolog-Hematolog.ro CrossRef
8. Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
   Li-Chung Chiu et al, 2021, Vaccines CrossRef
9. An Overview of Promising Biomarkers in Cancer Screening and Detection
   Saba Hasan, 2020, Current Cancer Drug Targets CrossRef
10. Advanced Melanoma
    Alexandra M. Haugh et al, 2021, Hematology/Oncology Clinics of North America CrossRef
11. Checkpoint Molecules in Rheumatology—or the Benefits of Being Exhausted
    Stinne Ravn Greisen et al, 2021, Current Rheumatology Reports CrossRef
12. Targeting immune checkpoint pathways in melanoma: triumphs and challenges
    Patricia Ines Back et al, 2023, Future Drug Discovery CrossRef
13. Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy
    Jiang Chen et al, 2024, Cancer Immunology Research CrossRef
14. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability
    Katiane Tostes et al, 2023, International Journal of Molecular Sciences CrossRef
15. Editorial: Application of artificial intelligence in improving immunotherapeutic efficacy
    Jie Li et al, 2022, Frontiers in Pharmacology CrossRef
16. Prognostic and Predictive Markers for Immunotherapy in Non Small Cell Lung Cancer
    null null et al, 2023, Journal of Medical and Radiation Oncology CrossRef